Hopeful Lipid-Busters to Watch at AHA: New GLP-1, Gene Therapy, Oral PCSK9 Inhibitor

(MedPage Today) — NEW ORLEANS — Innovations in lipid lowering get a major chance to shine, and potentially move the needle in cardiometabolic treatment, this weekend here at the American Heart Association (AHA) annual meeting.
Spearheading…

Source link : https://www.medpagetoday.com/meetingcoverage/aha/118368

Author :

Publish date : 2025-11-07 16:22:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Hopeful Lipid-Busters to Watch at AHA: New GLP-1, Gene Therapy, Oral PCSK9 Inhibitor

A distant galaxy is being strangled by the cosmic web

Smoldering Myeloma Gets First FDA-Approved Therapy

Related Posts

Trial Patient Dies After Receiving CRISPR Gene Therapy

Better Therapy, Care in Advanced Breast Cancer Has Led to Longer Survival

James Watson, Co-Discoverer of the Double-Helix Shape of DNA, Has Died at Age 97

DNA pioneer James Watson dies at 97

James Watson, co-discoverer of DNA’s double helix, has died aged 97

Comprehensive Testing Improves Angina After MINOCA

Trial Patient Dies After Receiving CRISPR Gene Therapy

Better Therapy, Care in Advanced Breast Cancer Has Led to Longer Survival

James Watson, Co-Discoverer of the Double-Helix Shape of DNA, Has Died at Age 97

DNA pioneer James Watson dies at 97

James Watson, co-discoverer of DNA’s double helix, has died aged 97

Comprehensive Testing Improves Angina After MINOCA

Fish Oil Cuts Risk of Serious Heart Events in Dialysis Patients

Enceladus’s ocean may be even better for life than we realised

Categories

Archives